REZIPRES Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Rezipres, and what generic alternatives are available?
Rezipres is a drug marketed by Dr Reddys Labs Sa and is included in one NDA.
The generic ingredient in REZIPRES is ephedrine hydrochloride. There are sixty-eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ephedrine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for REZIPRES?
- What are the global sales for REZIPRES?
- What is Average Wholesale Price for REZIPRES?
Summary for REZIPRES
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 39 |
| Patent Applications: | 706 |
| Drug Prices: | Drug price information for REZIPRES |
| What excipients (inactive ingredients) are in REZIPRES? | REZIPRES excipients list |
| DailyMed Link: | REZIPRES at DailyMed |
Pharmacology for REZIPRES
| Drug Class | Norepinephrine Releasing Agent alpha-Adrenergic Agonist beta-Adrenergic Agonist |
| Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
| Physiological Effect | Increased Norepinephrine Activity |
US Patents and Regulatory Information for REZIPRES
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr Reddys Labs Sa | REZIPRES | ephedrine hydrochloride | SOLUTION;INTRAVENOUS | 213536-001 | Jun 14, 2021 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dr Reddys Labs Sa | REZIPRES | ephedrine hydrochloride | SOLUTION;INTRAVENOUS | 213536-004 | Dec 7, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dr Reddys Labs Sa | REZIPRES | ephedrine hydrochloride | SOLUTION;INTRAVENOUS | 213536-002 | Jun 14, 2021 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
